-
Study Takes a Closer Look at Eye Cancer’s High Rate of Metastasis
23 Jul 2024 10:16 GMT
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Uveal melanoma is a rare cancer type with an …
-
Pembrolizumab Plus Chemo Receives Priority Review From the FDA for Advanced Pleural Mesothelioma
29 Jun 2024 16:29 GMT
… statistically significant improvement in overall survival (OS; HR, 0 … with unresected advanced pleural mesothelioma. The primary end … PFS and objective response rate (ORR) as assessed … advanced or metastatic malignant pleural mesothelioma. News release. Merck. …
-
Pleural mesothelioma: Symptoms and treatment
14 Jun 2024 12:06 GMT
… treatment for sarcomatoid pleural mesothelioma.
The primary treatment … for unresectable pleural mesothelioma is often chemotherapy. … stage. The median survival rate is between 9 and … case of pleural mesothelioma is different. Survival rates do not …
-
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
04 Jun 2024 12:41 GMT
… overall survival and key secondary endpoints include objective response rate … patients with unresectable malignant pleural mesothelioma (MPM).
OPDIVO® (nivolumab), … previously untreated unresectable malignant pleural mesothelioma, in combination with YERVOY …
-
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
03 Jun 2024 12:21 GMT
… statistical significance. Median overall survival for patients randomized to receive … to neurocognitive failure, overall survival, and radiological response rate) were planned to … with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or …
-
USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma
01 Jun 2024 08:57 GMT
… statistically significant improvement in overall survival (OS), reducing the risk … months respectively) and objective response rate (ORR) compared to chemotherapy alone … was permitted) alone.
“Malignant pleural mesothelioma is typically diagnosed in advanced …
-
US FDA grants priority review status to Merck's sBLA for Keytruda plus chemotherapy to treat metastatic malignant pleural mesothelioma
30 May 2024 09:05 GMT
… previously reported studies.
“Malignant pleural mesothelioma is typically diagnosed in advanced … patients with unresected advanced pleural mesothelioma. The study’s primary … pleural mesothelioma often progresses rapidly, and the five-year survival rate is …
-
FDA Prioritizes Keytruda Chemotherapy Mesothelioma Combo
30 May 2024 23:12 GMT
… (unresectable) or metastatic malignant pleural mesothelioma.
Dr. Gregory Lubiniecki, vice president … a far better overall response rate of 62% compared to 38% … and progression-free survival significantly advances the fight against mesothelioma.
The positive …
-
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
29 May 2024 11:33 GMT
… reported studies.
“Malignant pleural mesothelioma is typically diagnosed in advanced … permitted) alone.
About malignant mesothelioma
Malignant mesothelioma is a type of … pleural mesothelioma often progresses rapidly, and the five-year survival rate is …
-
FDA Grants Priority Review to Merck’s KEYTRUDA® Plus Chemotherapy as Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
29 May 2024 17:13 GMT
… statistically significant improvement in overall survival (OS), reducing the risk … months respectively) and objective response rate (ORR) compared to chemotherapy … reported studies.
“Malignant pleural mesothelioma is typically diagnosed in advanced …